Building Bridges: the future or small molecule-based cancer therapeutics

The development of cancer therapies is a high-risk, expensive and time-consuming process. More importantly, new therapies often are only effective in a subset of the intended patient population. Therefore, we urgently need to innovate the way we develop cancer therapies. At Oncode Accelerator, we do this through building bridges across relevant expertise to accelerate cancer drug development and impact lives.
Watch this recorded webinar which took place on December 17th, 2024, where Luc van Hijfte from Symeres and Anthe Janssen from Leiden University discuss how through public-private collaboration and incorporation of innovations such as artificial intelligence, the discovery and development of small molecule cancer therapies can be accelerated to the benefit of patients.
Luc van Hijfte's presentation starts at 6.30
Anthe Janssen's presentation starts at 25.30
www.oncodeacce...